Jim Cramer, Fed and tech stocks
Jim Cramer said during his latest program on CNBC that the Federal Reserve wanted to contain inflation and make sure it’s ...
Viking Therapeutics received an Overweight rating and a December 2025 price target of $80 from JPMorgan analysts.
CNBC’s Jim Cramer said the Fed’s successful start to the easing cycle is leading the market in a positive direction.
CNBC’s Jim Cramer on Thursday reviewed stocks that have historically performed well just after the a cutting cycle starts and endorsed his favorites.
Stocks to Watch in September. Since Southern Co (NYSE:SO) ranks 7th on the list, it deserves a deeper look. Jim Cramer said ...
Mad Money” host Jim Cramer rings the lightning round bell, which means he’s giving his answers to callers’ stock questions at ...